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Sudden unexpected death in epilepsy (SUDEP) is a major cause of premature death 
related to epilepsy. The causes of SUDEP remain unknown, but cardiac arrhythmias and 
asphyxia have been suggested as a major mechanism of this event. Inflammation has 
been implicated in the pathogenesis of both epilepsy and ventricular arrhythmia, with 
interleukin-6 (IL-6) being recognized as a crucial orchestrator of inflammatory states. 
Our group previously reported that levels of IL-6 were increased in the hearts of epileptic 
rats. In this scenario, anti-inflammatory actions are among the beneficial effects of fish 
oil dietary supplementation. This investigation revealed that elevated levels of IL-6 in the 
heart were markedly reduced in epileptic rats that were treated in the long-term with fish 
oil, suggesting protective anti-inflammatory actions against dangerously high levels of 
IL-6. Based on these findings, our results suggest beneficial effects of long-term intake 
of fish oil in reducing the inflammation associated with chronic epilepsy.
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inTrODUcTiOn
The mortality rate in people with epilepsy is substantially higher than that observed in the general 
population, which is a matter of concern among specialists (1). In this scenario, sudden unexpected 
death in epilepsy (SUDEP) is a leading cause of premature mortality directly related to epilepsy (2).
Sudden unexpected death in epilepsy is defined as “sudden, unexpected, witnessed or unwitnessed, 
non-traumatic and non-drowning death in patients with epilepsy, with or without evidence for a seizure, 
and excludes documented Status epilepticus (SE), in which postmortem examination does not reveal 
a toxicological or anatomic cause for death” (3). The fatal event is most likely provoked by functional 
disturbance, and researchers have proposed cardiac arrhythmia as a potential cause of SUDEP (2). 
Recently, clinically relevant genetic variants in cardiac arrhythmia and epilepsy have been found in a 
considerable number of SUDEP cases (4). Inflammation has been implicated in the pathophysiological 
events of both epilepsy and life-threatening ventricular arrhythmia (5, 6), in which the central role 
of the interleukin-6 (IL-6) is well recognized.
FigUre 1 | Immunoblot of interleukin-6 (IL-6). IL-6 levels in hearts of rats 
from control and epilepsy groups treated with vehicle or fish oil (85 mg/kg). 
The PVDF membrane was probed with anti-IL-6 antibody and re-probed with 
anti-β-actin. Each bar represents the mean ± SEM of the ratio IL-6/β-actin 
from four individual experiments (*p < 0.05; ***p < 0.001).
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Our group was the first to describe increased levels of IL-6 
in the hearts of rats with chronic epilepsy (7). Omega-3 polyun-
saturated fatty acids, which are abundant in fish oil, have been 
described as potent anti-inflammatory agents (8). Thus, in the 
search for complementary therapy for epilepsy, this study was 
conducted to examine the potential anti-inflammatory effects of 
fish oil supplementation on the levels of the pro-inflammatory 
cytokine IL-6 in the heart of rats with chronic epilepsy.
aniMals anD MeThODs
animals
Adult male Wistar rats (220–280  g) were housed under stand-
ard controlled conditions (7:00 a.m./7:00 p.m. light/dark cycle; 
20–22°C; 45–55% humidity) with food and water ad  libitum. 
All animal experiments were carried out in accordance with the 
National Institutes of Health guide for care and use of laboratory 
animals and approved by the Animal Care Committee of UNIFESP 
(CEUA 188439).
induction of epilepsy
Epilepsy was induced according to the procedure described pre-
viously (9). In brief, 30 min after methyl scopolamine injection 
(1 mg/kg, s.c.—Sigma, MO, USA), pilocarpine was administered 
(350 mg/kg, i.p.—Sigma, MO, USA). Animals developed SE. To 
terminate SE, diazepam (10  mg/kg—Cristalia, Compaz) was 
administered subcutaneously 3  h after SE onset. Rats evolved 
through the latent period to the chronic phase of the pilocarpine 
model. To confirm the presence of epilepsy, animals were continu-
ously video monitored for 60  days, and spontaneous recurrent 
seizures observed. At the end, nine rats with epilepsy (n = 9) were 
used in the experiments.
Fish Oil Treatment
Animals were randomly divided into the following groups: 
(1) animals treated daily with vehicle (0.009% cremophor) (control 
vehicle); (2) animals treated daily with 85 mg/kg fish oil (control 
fish oil); (3) animals with epilepsy treated daily with vehicle (epi-
lepsy vehicle); and (4) animals with epilepsy treated with 85 mg/kg 
fish oil (epilepsy fish oil). During the 90-day treatment, animals 
received vehicle (cremophor 0.009%) or fish oil (PROEPA®, 
85 mg/kg). A single daily dose was given via oral gavage between 
11:00 and 12:00 a.m. Volume was adjusted according to animal 
weight, which was verified three times a week during the 90-day 
treatment period. Each fish oil capsule contained eicosapentaenoic 
acid (EPA), 180 mg, and docosahexaenoic acid (DHA), 120 mg. 
Capsule contents were dissolved in 0.009% cremophor, yielding 
a final concentration of 21.25 mg/ml fish oil, corresponding to 
3.82 mg/ml EPA and 2.55 mg/ml DHA, and the final composition 
of fish oil was administered as 1 ml/250 g of body weight. Animals 
were killed by decapitation. Hearts were removed, and ventricles 
were separated and split in half (for Western blot and ELISA 
procedures) and then stored at −80°C until use.
Measurements of il-6 Protein levels
One half of the ventricle was used for the Western blotting proce-
dure, and the other half was used for the ELISA assay. For Western 
blot analysis, samples were prepared as previously described by 
Nejm et  al. (10). The primary antibodies used were anti-IL-6 
(Millipore-Chemicon, USA) and anti-β-actin (Sigma Aldrich, 
USA). ELISA assays (DuoSet ELISA, R&D Systems, Minneapolis, 
MN, USA) were performed following the recommendations of 
the manufacturer. All samples were run in duplicate, and the 
mean value was reported.
statistical analysis
Data were expressed as the mean ±  standard error. Statistical 
analysis was performed using two-way ANOVA [grouped as 
control versus experimental and by treatment (vehicle versus fish 
oil)] followed by Bonferroni posttest. p Values of 0.05 or less were 
considered significant.
resUlTs
The results of Western blot analysis showed that IL-6 levels in 
the heart of rats with epilepsy were substantially increased when 
compared with control rats [F(1;12) = 54.78; p < 0.0001]. Animals 
with epilepsy that were treated with fish oil for an extended time 
exhibited a marked reduction in IL-6 levels, since an interaction 
effect was observed between epilepsy and fish oil treatment 
[F(1;12) = 5.34; p = 0.039], as shown in Figure 1.
In Figure  2, the ELISA results corroborated the results 
obtained with immunoblotting analysis as increased levels of IL-6 
were found in the hearts of animals with epilepsy compared with 
those in control rats [F(1;16) = 10.26; p = 0.0059]. Furthermore, 
FigUre 2 | Interleukin-6 (IL-6) quantification by ELISA. IL-6 levels in the 
hearts of rats in control and epilepsy groups treated with vehicle or fish oil 
(85 mg/kg) for 90 days. Each bar represents mean ± SEM of five individual 
experiments (*p < 0.05; **p < 0.01).
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the ELISA results show the effectiveness of the fish oil treat-
ment, which reduced IL-6 levels in both control and epileptic 
rats [F(1;16)  =  6.05; p  =  0.0264]. There was no interaction 
effect between epilepsy and fish oil treatment [F(1;16) =  1.06; 
p = 0.3178].
DiscUssiOn
In this rodent pilocarpine model of seizures, fish oil supplementa-
tion reduced cardiac levels of IL-6, indicating an anti-inflammatory 
effect of fish oil.
Consistent preclinical and clinical findings support the pres-
ence of a persistent inflammatory condition in the brain and 
plasma of subjects with epilepsy (4, 6, 11). Epileptic seizures 
often affect heart rate and rhythm, and poor seizure control is 
by far the major clinical risk factor for SUDEP (2). However, 
despite the available therapeutic arsenal, 30–40% of individuals 
with epilepsy have uncontrolled seizures. Studies focused on the 
pathological basis of epilepsy have focused on the role of inflam-
matory events (6). Basic and clinical studies has been described 
that chronic inflammatory state contribute to the pathogenesis 
of seizures and maintance of epilepsy (6, 11, 12). Previously, we 
demonstrated chronically elevated levels of the pro-inflammatory 
cytokine IL-6 in the ventricles of rats with seizures (7). Here, our 
findings support the existence of persistent inflammation in the 
ventricles of rats with epilepsy, which exhibited elevated levels of 
IL-6. Elevated circulating levels of IL-6 have been described in 
patients with heart failure, and these higher levels are positively 
correlated with the presence and duration of cardiac arrhythmias 
and with the severity of disease and mortality risk (5, 13). Taken 
together, there is compelling evidence that increased levels of 
IL-6 are deeply involved in the pathophysiological mechanisms 
underlying both epilepsy and cardiac diseases.
Using the pilocarpine model of epilepsy, Ferrari and colleagues 
in our group demonstrated that chronic treatment with fish oil 
promoted neuroprotection and positive plastic changes in the 
brain of rats with epilepsy (14). The beneficial anti-inflammatory 
effects of omega-3 fatty acids in chronic inflammatory diseases 
have been consistently documented (8). Fish oil dietary con-
sumption is suggested as a good source of omega-3 polyunsatu-
rated fatty acids for consumers. This study suggests that chronic 
oil fish supplementation has a protective anti-inflammatory 
effect against elevated levels of IL-6 in the heart of rats with 
epilepsy, but the underlying mechanisms of these effects remain 
unknown.
cOnclUsiOn
Our findings report the beneficial anti-inflammatory effects of 
long-term oil fish intake in the hearts of rats with chronic inflam-
mation associated with epilepsy. Our results suggest the potential 
therapeutic value of dietary supplementation with oil fish in 
patients with epilepsy.
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